Decreased B16F10 melanoma growth and impaired tumour vascularization in BDF1 mice with quercetin-cyclodextrin binary system

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 10, 2006, Pages 1351-1358

  Kale, Rajendrakumar ^a   Saraf, Madhusudan ^a   Juvekar, Aarti ^b   Tayade, Pralhad ^a,c  

^a BOMBAY COLLEGE OF PHARMACY   (India)

^b Research and Education in Cancer   (India)

^c Y T Institute of Pharmacy   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN SULFOBUTYL ETHER; QUERCETIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CRYSTALLIZATION; DRUG ACCUMULATION; DRUG INHIBITION; DRUG POTENTIATION; DRUG SOLUBILITY; FEMALE; GROWTH INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; INFRARED SPECTROSCOPY; MELANOMA; MOUSE; NONHUMAN; SOLID STATE; TUMOR VASCULARIZATION; TUMOR VOLUME;

ANIMALS; CHEMISTRY, PHYSICAL; CYCLODEXTRINS; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; FEMALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED STRAINS; NEOVASCULARIZATION, PATHOLOGIC; PHYSICOCHEMICAL PHENOMENA; QUERCETIN; SOLUBILITY; WATER;

EID: 33750087319     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.10.0008     Document Type: Article

References (20)

1. Abad, M., Bermejo, P., Villar, A., Vaverdes, S. (1993) Anti-inflammatory activity of two flavonoids from Tanacetum microphyllum. J. Nat. Prod. 56: 1164-1167
2. Bosisio, B., Pirola, O. (1992) Effect of the flavanolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes. Pharmacol. Res. 25: 147-154
3. Boulmedarat, L., Bochot, A., Lesieur, S., Fattal, E. (2004) Toward the mechanism of destabilization of lipid membranes by methylated beta cyclodextrins. Presented at 12th International Cyclodextrin Symposium, Montpellier, France. Abstract book, p. 8.
4. Cassady, J. (1990) Natural products as a source of potential cancer chemotherapeutic and chemopreventive agents. J. Nat. Prod. 53: 23-41
5. Della, L., Ragazzi, E., Tubaro, A. (1988) Anti-inflammatory activity of benzopyrones that are inhibitors of cyclo- and lipo-oxygenase. Pharmacol. Res. Commun. 20: S91-S94
6. Ficarra, R., Tommasini, S., Raneri, D., Calabro, M., Di Bella, M., Rustichelli, C., Gamberini, M., Ficarra, P. (2002) J. Pharm. Biomed. Anal. 29: 1005-1014
7. Garcia, R., Gonzalez, A., Agudo, A., Riboli, E. (1999) High intake of specific carotenoids and flavonoids does not reduce the risk of bladder cancer. Nutr. Cancer 35: 212-214
8. Higuchi, T., Connors, K. A. (1965) Phase solubility techniques. Adv. Anal. Chem. Inst. 4: 117-212
9. Hirayama, F., Uekama, K. (1999) Cyclodextrin based controlled drug release system. Adv. Drug Deliv. Rev. 36: 125-141
10. Ikeda, K., Uekama, K., Otagiri, M. (1975) Inclusion complexes of β-cyclodextrin with anti-inflammatory drug fenamates in aqueous solution. Chem. Pharm. Bull. 23: 201-208
11. Jackson, J., Seed, M., Kircher, C., Willoughby D., Winkler, J. (1997) The codependence of angiogenesis and chronic inflammation. FASEB J. 11: 457-465
12. Kim, K., Frank M., Henderson, N. (1985) Applications of differential scanning calorimetry to the study of solid drug dispersions. J. Pharm. Sci. 74: 283-289
13. Larocca, L., Piantelli, M., Leone, G. (1990) Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoids. Br. J. Haematol. 75: 489-495
14. Loftsson, T., Frioriksdottir, H., Ingvarsdottir, G., Jonsdottir B., Siguroardottir, A. (1994) The influence of 2-hydroxypropyl-cyclodextrin on diffusion rates and transdermal delivery of hydrocortisone. Drug Dev. Ind. Pharm. 20: 1699-1708
15. Ono, N., Arima, H., Hirayama, F., Uekama, K. (2001) A moderate interaction of maltosyl-α-cyclodextrin with Caco-2 cells in comparision with the parent cyclodextrin. Biol. Pharm. Bull. 24: 395-402
16. Ren, W., Qiao, Z., Wang, H., Zhu, L., Zhang, L. (2003) Flavonoids: promising anticancer agents. Med. Res. Rev. 23: 519-534
17. Scambia, G., Ranelletti, F., Panici, P. (1990) Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells. Br. J. Cancer 62: 942-946
18. Skehan, P., Strong, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D. (1990) New colorimetric cytotoxicity assay for anticancer drug screening. J. Natl Cancer Inst. 83: 1107-1112
19. Tayade, P., Kale, R. (2004) Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis. J. Pharm. Biomed. Anal. 34: 333-339
20. Verma, A., Johnson, J., Gould, M., Tanner, M. (1988) Inhibition of 7,12-dimethylbenz (a) anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res. 48: 5754-5758